According to Ovid Therapeutics 's latest financial reports the company's current EPS (TTM) is -ยฃ0.54. In 2022 the company made an earnings per share (EPS) of -ยฃ0.60 a decrease over its 2021 EPS that were of ยฃ1.37.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -ยฃ0.58 | -2.55% |
2022 | -ยฃ0.60 | -143.5% |
2021 | ยฃ1.37 | -226.43% |
2020 | -ยฃ1.08 | -11.39% |
2019 | -ยฃ1.22 | -25.47% |
2018 | -ยฃ1.64 | -23.94% |
2017 | -ยฃ2.16 | 143.74% |
2016 | -ยฃ0.88 |